Streetbeat News

Equity Actions

F

Seven analysts have recently reviewed Ford Motor (NYSE:F), showing a mix of opinions with an average 12-month price target of $13.43, down from $14.67. The ratings range from bullish to bearish, with recent actions including upgrades and new ratings. Ford's financial health is highlighted by a 4.46% revenue growth, a net margin of -1.14%, and a debt-to-equity ratio of 3.53. The company's strategic division into Ford Blue and Ford Model e is noted, alongside its significant market share in the US, UK, and China.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 5:00 pm

ASO

Academy Sports (NYSE:ASO) has seen an increase in short interest, with 8.80 million shares sold short, representing 22.32% of its float. This is above the peer group average of 15.52%. High short interest can indicate bearish market sentiment but can also be bullish if investors anticipate a short squeeze.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 5:00 pm

PFE

Recent options activity for Pfizer (NYSE:PFE) indicates a bearish stance by big-money investors, with a split sentiment of 46% bullish and 53% bearish. A total of 13 options trades were detected, including 1 put and 12 calls, with a focus on a price band between $20.0 and $35.0. Significant trades include both bearish and bullish calls with varying strike prices and expiration dates. Pfizer's current market status shows a slight decrease in stock price, with an RSI indicating a potential overbought situation. Analyst opinions vary, with an average target price of $42.0, but recent downgrades suggest caution.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:31 pm

DCTH

Delcath Systems shares are trading higher following the announcement of a $7 million private placement.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 4:19 pm

GBTC

IBIT

Bitcoin spot ETFs experienced mixed fortunes with a total net inflow of $132 million, despite market volatility. Grayscale ETF (GBTC) saw a net outflow of $257 million, while BlackRock's IBIT ETF recorded a net inflow of $345 million. The cryptocurrency market, including Bitcoin and Ether, faced significant volatility, with institutional investors unwinding positions and the Bitcoin forward curve declining, indicating a potential shift in investor sentiment.

Portfolio Pulse from Murtuza Merchant

March 15, 2024 | 4:16 pm

AVD

CDLX

CISS

IMRX

SLS

VERB

U.S. stocks traded lower with the Dow Jones, NASDAQ, and S&P 500 all falling. Energy shares rose by 0.6%, while information technology shares fell by 0.9%. Consumer sentiment in March dropped to its lowest in three months. Verb Technology, Cardlytics, and American Vanguard saw significant stock price increases, while C3is, SELLAS Life Sciences, and Immuneering Corporation experienced notable declines. Oil and gold prices fell, while silver and copper prices rose.

Portfolio Pulse from Avi Kapoor

March 15, 2024 | 4:05 pm

EXPD

Analysts have provided diverse opinions on Expeditors Intl (NYSE:EXPD) over the last three months, with recent ratings showing a shift towards a more bearish stance. The average 12-month price target for EXPD has increased to $115.6, reflecting a 4.45% rise from the previous target. Despite a challenging quarter with a -33.82% decline in revenue growth, Expeditors Intl maintains strong financial health indicators, including a high net margin and ROE. Analysts' actions and price target adjustments highlight their evolving expectations for the company.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

CSIQ

Recent analyst ratings for Canadian Solar (NASDAQ:CSIQ) show a mixed sentiment, with a majority being indifferent and one bearish over the past three months. The average 12-month price target has been adjusted to $22.02, marking a 7.71% decrease from the previous target. Analyst actions include both lowering and raising price targets, reflecting varied expectations for the company's performance. Canadian Solar's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management provide a comprehensive view of its market position and operational efficiency.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

META

The analysis compares Meta Platforms (META) with its competitors in the Interactive Media & Services industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Meta shows strong operational performance with higher ROE, EBITDA, gross profit, and revenue growth compared to industry averages, despite its valuation metrics suggesting potential overvaluation.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

EVH

Analysts have recently updated their ratings and price targets for Evolent Health (NYSE:EVH), showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target is now $45.0, down from $45.67. Actions include lowering and raising price targets by analysts from JP Morgan, Oppenheimer, JMP Securities, and Canaccord Genuity. Evolent Health's financial performance is strong, with notable revenue growth, net margin, ROE, ROA, and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm